Meet the Expert Series: Video On Demand-Dr. Brendon Neuen
Dr. Brendon Neuen

Dr. Brendon Neuen

George Institute for Global Health Australia

  • Staff Specialist Nephrologist and Director of the Kidney Trials Unit at Royal North Shore Hospital
  • Senior Research Fellow at the George Institute for Global Health, Australia
  • Medical Degree at James Cook University with 1st Class Honours and an Academic Medal
  • Masters in Global Health and Epidemiology from the University of Oxford under Clarendon Scholarship
  • PhD, University of New South Wales with the Faculty Award for outstanding contribution to research
  • Fellow of the Royal Australasian College of Physicians and a Fellow of the American Society of Nephrology
  • Founding Secretariat of the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium (SMART-C)
  • He has published over 70 peer-reviewed articles in general medical and specialty journals (e.g. The Lancet, BMJ and Annals of Internal Medicine, Lancet Diabetes and Endocrinology, Circulation, and the Journal of the American Society of Nephrology)
  • Serving on boards or committees of the Australasian Kidney Trials Network, Australian and New Zealand Society of Nephrology, and the International Society of Nephrology
  • Editorial Fellow of the Journal of the American Society of Nephrology from 2019-2020

What is the Impact in the composite of Kidney Disease Progression and CV Death in CKD patients based on Albuminuric status A1, A2, and A3?